Yeda Research and Develpment & Co. Ltd

The Brigham and Women's Hospital, Inc.

Id Biomedical Corporation of Quebec

Ruth Maron

Howard L Weiner

Michael Sela

Ruth Arnon

Yosef Yarden

David S Burt

Dan Frenkel

Bilha Schechter

Esther Hurvitz

Georg Mahlknecht

Ron Levy

Monomeric and multimeric aptamers are provided. Also provided are pharmaceutical compositions which comprise same and methods of using same.

Aptamers, multimeric aptamers and uses thereof

An article-of-manufacture is provided. The article-of-manufacture comprises a packaging material identified for treating cancer, packaging: Also provided are pharmaceutical compositions and methods of using the above antibodies as well as other antibody combinations for the treatment of cancer.

Combinations of anti ErbB antibodies for the treatment of cancer

Novel pharmaceutically active compositions of matter comprise in combination a low-molecular-weight anti-cancer drug chemically linked to antibodies selective or specific to tumor antigens. The preferred linkage is via covalent bonds, whether directly or via a linking agent. A method of treatment of mammals afflicted with malignant growth comprises administering a pharmaceutical composition of matter defined above.

Pharmaceutically active compositions containing adriamycin and daunomycin

Chemotherapeutic agents comprising an antigen binding dimer derived from an immunoglobulin covalently bound to a drug are disclosed. The dimer and drug are bound, while preserving both the antibody activity of the dimer and the pharmacological activity of the drug.

Immunologic chemotherapeutic agents comprising antigen binding dimers

Growing community of inventors

Rehovot, Israel

Ruth Maron